$ONTX News
Small caps push ahead, large caps lag 10:55 a.m. Oct. 3, 2013 - The Trading Deck
A Glance At Our Winners And Losers In 2013 5:22 p.m. Dec. 31, 2013 - Seeking Alpha
Cervical Cancer Should Not Be Ignored By Biotech Investors 9:59 a.m. Dec. 24, 2013 - Seeking Alpha
Onconova Reports Combination of Rigosertib, Gemcitabine Unlikely to Demonstrate Statistically Significant Improvement i 3:48 p.m. Dec. 17, 2013 - benzinga.com
Onconova Presents Positive Data from Clinical Trials of Rigosertib in MDS at ASH 6:15 a.m. Dec. 9, 2013 - benzinga.com
10-Q: ONCONOVA THERAPEUTICS, INC. 3:16 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Onconova Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 7:56 p.m. Nov. 12, 2013 - Seeking Alpha
UPDATE: Citigroup Upgrades Onconova Therapeutics on Favorable Risk-Reward 9:00 a.m. Oct. 29, 2013 - benzinga.com
Tech IPOs Hot As Investors OK With Companies In Red 4:53 p.m. Sept. 27, 2013 - Investors Business Daily
10-Q: ONCONOVA THERAPEUTICS, INC. 3:52 p.m. Sept. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
Pound For Pound, Are Biotechs Still Worth Their Salt? 4:12 p.m. Aug. 23, 2013 - Investors Business Daily
UPDATE: Piper Jaffray Initiates Onconova Therapeutics with Overweight on Multiple Positive Factors 8:39 a.m. Aug. 19, 2013 - benzinga.com
Our BioPharma Catalyst Watch List 7:30 a.m. Aug. 15, 2013 - Seeking Alpha
Onconova Times The IPO Wave To Perfection 3:15 p.m. Aug. 6, 2013 - Seeking Alpha
3 Near-Term Catalysts Could Double Onoconova's Valuation 6:55 a.m. Aug. 5, 2013 - Seeking Alpha
Onconova's Public Debut: What You'll Want To Know 4:24 p.m. July 26, 2013 - Seeking Alpha
Onconova Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:43 a.m. Jan. 6, 2014 - GlobeNewswire
Clinical Study Results, Pending Applications, Trial Updates, and Discontinued Trials - Research Report on ICU Medical, Exelixis, Cempra, Exact Sciences, and Onconova 8:00 a.m. Dec. 25, 2013 - PR Newswire
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study 4:45 p.m. Dec. 17, 2013 - GlobeNewswire
Onconova Therapeutics, Inc. [ONTX] to Ring The NASDAQ Stock Market Closing Bell 10:00 a.m. Dec. 16, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Onconova Therapeutics to Host Analyst Event in New York City on December 19th 11:14 a.m. Dec. 13, 2013 - GlobeNewswire
Onconova Announces Presentation of Positive Data From Clinical Trials of Rigosertib in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting 7:00 a.m. Dec. 9, 2013 - GlobeNewswire
Onconova Therapeutics, Inc. to Present at the 25th Annual Piper Jaffray Healthcare Conference 9:00 a.m. Nov. 27, 2013 - GlobeNewswire
Upcoming Webinars, FDA Clearances, Preclinical Data Presentations, Completed Acquisitions and Financial Results - Research Report on Teva, Boston Scientific, Alnylam, Wright Medical, and Onconova 8:00 a.m. Nov. 25, 2013 - PR Newswire
Edison expands international bio-pharmaceutical presence with launch of coverage of Onconova Therapeutics 9:47 a.m. Nov. 19, 2013 - PR Newswire
Onconova Therapeutics, Inc. Reports Third Quarter 2013 Financial and Operational Results 4:01 p.m. Nov. 12, 2013 - GlobeNewswire
Onconova Announces Presentation of Rigosertib Clinical Data in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting 9:37 a.m. Nov. 7, 2013 - GlobeNewswire
Onconova Therapeutics, Inc. Announces Timing for Third Quarter 2013 Financial Results and Conference Call 6:04 p.m. Nov. 5, 2013 - GlobeNewswire
Onconova Therapeutics, Inc. Reports Second Quarter 2013 Financial and Operational Results 1:27 p.m. Sept. 6, 2013 - GlobeNewswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on AGIO, EPZM, ONTX and XON 7:30 a.m. Aug. 26, 2013 - ACCESSWIRE
RDInvesting Provides Investors with Free In-Depth Equity Reports on AGIO, HUN, KALU and ONTX 8:01 a.m. Aug. 20, 2013 - ACCESSWIRE
Onconova Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option 3:05 p.m. July 30, 2013 - GlobeNewswire
Onconova Appoints Dr. Jerome Groopman and Anne VanLent to Board of Directors 6:00 a.m. July 29, 2013 - BusinessWire
Small caps push ahead, large caps lag 10:55 a.m. Oct. 3, 2013 - The Trading Deck
A Glance At Our Winners And Losers In 2013 5:22 p.m. Dec. 31, 2013 - Seeking Alpha
Cervical Cancer Should Not Be Ignored By Biotech Investors 9:59 a.m. Dec. 24, 2013 - Seeking Alpha
Onconova Reports Combination of Rigosertib, Gemcitabine Unlikely to Demonstrate Statistically Significant Improvement i 3:48 p.m. Dec. 17, 2013 - benzinga.com
Onconova Presents Positive Data from Clinical Trials of Rigosertib in MDS at ASH 6:15 a.m. Dec. 9, 2013 - benzinga.com
10-Q: ONCONOVA THERAPEUTICS, INC. 3:16 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Onconova Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 7:56 p.m. Nov. 12, 2013 - Seeking Alpha
UPDATE: Citigroup Upgrades Onconova Therapeutics on Favorable Risk-Reward 9:00 a.m. Oct. 29, 2013 - benzinga.com
Tech IPOs Hot As Investors OK With Companies In Red 4:53 p.m. Sept. 27, 2013 - Investors Business Daily
10-Q: ONCONOVA THERAPEUTICS, INC. 3:52 p.m. Sept. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
Pound For Pound, Are Biotechs Still Worth Their Salt? 4:12 p.m. Aug. 23, 2013 - Investors Business Daily
UPDATE: Piper Jaffray Initiates Onconova Therapeutics with Overweight on Multiple Positive Factors 8:39 a.m. Aug. 19, 2013 - benzinga.com
Our BioPharma Catalyst Watch List 7:30 a.m. Aug. 15, 2013 - Seeking Alpha
Onconova Times The IPO Wave To Perfection 3:15 p.m. Aug. 6, 2013 - Seeking Alpha
3 Near-Term Catalysts Could Double Onoconova's Valuation 6:55 a.m. Aug. 5, 2013 - Seeking Alpha
Onconova's Public Debut: What You'll Want To Know 4:24 p.m. July 26, 2013 - Seeking Alpha
Onconova Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:43 a.m. Jan. 6, 2014 - GlobeNewswire
Clinical Study Results, Pending Applications, Trial Updates, and Discontinued Trials - Research Report on ICU Medical, Exelixis, Cempra, Exact Sciences, and Onconova 8:00 a.m. Dec. 25, 2013 - PR Newswire
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study 4:45 p.m. Dec. 17, 2013 - GlobeNewswire
Onconova Therapeutics, Inc. [ONTX] to Ring The NASDAQ Stock Market Closing Bell 10:00 a.m. Dec. 16, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Onconova Therapeutics to Host Analyst Event in New York City on December 19th 11:14 a.m. Dec. 13, 2013 - GlobeNewswire
Onconova Announces Presentation of Positive Data From Clinical Trials of Rigosertib in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting 7:00 a.m. Dec. 9, 2013 - GlobeNewswire
Onconova Therapeutics, Inc. to Present at the 25th Annual Piper Jaffray Healthcare Conference 9:00 a.m. Nov. 27, 2013 - GlobeNewswire
Upcoming Webinars, FDA Clearances, Preclinical Data Presentations, Completed Acquisitions and Financial Results - Research Report on Teva, Boston Scientific, Alnylam, Wright Medical, and Onconova 8:00 a.m. Nov. 25, 2013 - PR Newswire
Edison expands international bio-pharmaceutical presence with launch of coverage of Onconova Therapeutics 9:47 a.m. Nov. 19, 2013 - PR Newswire
Onconova Therapeutics, Inc. Reports Third Quarter 2013 Financial and Operational Results 4:01 p.m. Nov. 12, 2013 - GlobeNewswire
Onconova Announces Presentation of Rigosertib Clinical Data in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting 9:37 a.m. Nov. 7, 2013 - GlobeNewswire
Onconova Therapeutics, Inc. Announces Timing for Third Quarter 2013 Financial Results and Conference Call 6:04 p.m. Nov. 5, 2013 - GlobeNewswire
Onconova Therapeutics, Inc. Reports Second Quarter 2013 Financial and Operational Results 1:27 p.m. Sept. 6, 2013 - GlobeNewswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on AGIO, EPZM, ONTX and XON 7:30 a.m. Aug. 26, 2013 - ACCESSWIRE
RDInvesting Provides Investors with Free In-Depth Equity Reports on AGIO, HUN, KALU and ONTX 8:01 a.m. Aug. 20, 2013 - ACCESSWIRE
Onconova Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option 3:05 p.m. July 30, 2013 - GlobeNewswire
Onconova Appoints Dr. Jerome Groopman and Anne VanLent to Board of Directors 6:00 a.m. July 29, 2013 - BusinessWire
